Nasdaq

Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy

MINNEAPOLIS, July 14, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ ...
Labroots

Revolutionizing Quantitative Bioanalytical Testing: The Next Leap in Simple Western Technology

Analyzing protein expression in biological samples has traditionally been challenging and often poorly reproducible. While methods like western blot have been around for decades, Simple Western™ ...
Nasdaq

Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System

MINNEAPOLIS, March 10, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has begun shipping the Leo™ System, powered by Simple Western™ Technology. Leo expands upon ...
Labroots

Revolutionize Protein Quantitation With Leo - A High-Throughput, Fully Automated Simple Western System That Provides Results in as Little as 3 Hours.

Bio-Techne is proud to provide a first glimpse into the power and performance of the Leo™ System using several assay models as it hits the market. Data highlights include throughput, sensitivity, ...
Morningstar

Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy

MINNEAPOLIS, July 14, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ ...